Scholarly Index
L. Masana
Hospital Universitari Sant Joan de Reus; 30,042 total citations; 594 total publications; best world rank #50
Hospital Universitari Sant Joan de Reus
30,042Total citations
594Total publications
63H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Lipoproteins and Cardiovascular Health | Lifetime | 289 | ES 2 | 98.70 |
| Cancer, Lipids, and Metabolism | Lifetime | 424 | ES 8 | 98.37 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 406 | ES 2 | 98.60 |
| Lipid metabolism and disorders | Lifetime | 264 | ES 8 | 97.06 |
| Peroxisome Proliferator-Activated Receptors | Lifetime | 605 | ES 18 | 96.24 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 874 | ES 19 | 95.06 |
| Pharmaceutical Economics and Policy | Lifetime | 981 | ES 14 | 91.13 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 98 | ES 1 | 97.60 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 389 | ES 7 | 96.33 |
| Lipid metabolism and disorders | 2021-2025 | 50 | ES 1 | 93.58 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 238 | ES 4 | 94.19 |
| Pharmaceutical Economics and Policy | 2021-2025 | 251 | ES 10 | 87.42 |
| Medication Adherence and Compliance | 2021-2025 | 800 | ES 29 | 71.43 |